Stay updated on Fruquintinib in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Fruquintinib in Solid Tumors Clinical Trial page.

Latest updates to the Fruquintinib in Solid Tumors Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe screenshots indicate only minor UI/formatting adjustments and an updated timestamp, with no changes to core study details, eligibility criteria, outcomes, or safety information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check33 days agoChange DetectedAdded a government-status notice and updated version to v3.2.0; removed the previous version tag v3.1.0.SummaryDifference2%

- Check40 days agoChange DetectedUpdated version from v3.0.2 to v3.1.0, indicating a new release. No other content changes were detected.SummaryDifference0.0%

- Check54 days agoChange DetectedVersion bumped to v3.0.2 (replacing v3.0.1). The 'Back to Top' link/button was removed.SummaryDifference0.1%

- Check61 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.1%

- Check68 days agoChange DetectedThe web page has been updated to include new drug information for Fruquintinib and relevant publications, while some location details and previous versions have been removed.SummaryDifference3%

Stay in the know with updates to Fruquintinib in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fruquintinib in Solid Tumors Clinical Trial page.